{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:27:31Z","timestamp":1791228451225,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.det.2023.12.004","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T08:28:02Z","timestamp":1704356882000},"page":"247-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hidradenitis Suppurativa-Related Autoinflammatory Syndromes"],"prefix":"10.1016","volume":"42","author":[{"given":"Carlo Alberto","family":"Maronese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Moltrasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Valerio","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.det.2023.12.004_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12016-017-8621-8","article-title":"A\u00a0Comprehensive Review of Neutrophilic Diseases","volume":"54","author":"Marzano","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.det.2023.12.004_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40257-017-0265-1","article-title":"PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment","volume":"18","author":"Cugno","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib3","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clindermatol.2020.10.016","article-title":"PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa","volume":"39","author":"Garcovich","year":"2021","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/bjd.14691","article-title":"Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation","volume":"175","author":"Marzano","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib5","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1111\/jdv.14464","article-title":"Recognizing syndromic hidradenitis suppurativa: a review of the literature","volume":"31","author":"Gasparic","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/bjd.21674","article-title":"Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence","volume":"187","author":"Pavlovsky","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib7","article-title":"Hidradenitis Suppurativa in a Patient with Smith-Magenis Syndrome: A Case Report","volume":"11","author":"McKenzie","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.det.2023.12.004_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A\u00a0new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.det.2023.12.004_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/11.8.961","article-title":"Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder","volume":"1","author":"Wise","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.det.2023.12.004_bib10","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1182\/blood-2013-07-516948","article-title":"The F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages","volume":"123","author":"Starnes","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.det.2023.12.004_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/art.41976","article-title":"Excess Serum Interleukin-18 Distinguishes Patients With Pathogenic Mutations in PSTPIP1","volume":"74","author":"Stone","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jid.2020.08.028","article-title":"Phenotypic Associations of PSTPIP1 Sequence Variants in PSTPIP1-Associated Autoinflammatory Diseases","volume":"141","author":"Boursier","year":"2021","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jdcr.2022.11.030","article-title":"Renal involvement as a potential feature of pyogenic arthritis, pyoderma gangrenosum, and acne syndrome with E250K mutation of PSTPIP1 gene","volume":"32","author":"Zhao","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib14","article-title":"Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa","volume":"4","author":"Morales-Heil","year":"2023","journal-title":"HGG Adv"},{"key":"10.1016\/j.det.2023.12.004_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13052-019-0705-z","article-title":"PAPA and FMF in two siblings: possible amplification of clinical presentation? A case report","volume":"45","author":"Maggio","year":"2019","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.det.2023.12.004_bib16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bjd.17466","article-title":"Association of pyrin mutations and autoinflammation with complex phenotype hidradenitis suppurativa: a case-control study","volume":"180","author":"Vural","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaad.2010.12.025","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome","volume":"66","author":"Braun-Falco","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2230.2005.01897.x","article-title":"Pyoderma gangrenosum associated with hidradenitis suppurativa","volume":"30","author":"Ah-Weng","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archdermatol.2010.328","article-title":"Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review","volume":"146","author":"Hsiao","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib20","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/bjd.13668","article-title":"First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome","volume":"173","author":"Duchatelet","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib21","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/jid.2011.42","article-title":"PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa)","volume":"131","author":"Pink","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib22","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/MD.0000000000000187","article-title":"Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases","volume":"93","author":"Marzano","year":"2014","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.det.2023.12.004_bib23","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.det.2023.12.004_bib24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2020.00877","article-title":"Increased Prevalence of NLRP3 Q703K Variant Among Patients With Autoinflammatory Diseases: An International Multicentric Study","volume":"11","author":"Theodoropoulou","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.det.2023.12.004_bib25","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.12998\/wjcc.v9.i15.3506","article-title":"Association of hidradenitis suppurativa with Crohn's disease","volume":"9","author":"Zhang","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.det.2023.12.004_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155585","article-title":"Serum high-sensitivity C-reactive protein, tumor necrosis factor-\u03b1, interleukin (IL)-1\u03b2, IL-17A and IL-23 levels in patients with hidradenitis suppurativa","volume":"144","author":"Sara\u00e7 \u00d6zt\u00fcrk","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.det.2023.12.004_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/bjd.14383","article-title":"PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome","volume":"175","author":"Calder\u00f3n-Castrat","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib28","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jid.2016.02.801","article-title":"Whole Genome Linkage Analysis Followed by Whole Exome Sequencing Identifies Nicastrin (NCSTN) as a Causative Gene in a Multiplex Family with \u03b3-Secretase Spectrum of Autoinflammatory Skin Phenotypes","volume":"136","author":"Faraji Zonooz","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib29","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1111\/1346-8138.14259","article-title":"Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome","volume":"45","author":"Saito","year":"2018","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib30","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/1346-8138.15527","article-title":"First PSENEN mutation in PASH syndrome","volume":"47","author":"Zhang","year":"2020","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdermsci.2020.05.004","article-title":"Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach","volume":"99","author":"Brandao","year":"2020","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.det.2023.12.004_bib32","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2020.00847","article-title":"Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease","volume":"11","author":"Nomura","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.det.2023.12.004_bib33","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1159\/000521263","article-title":"Whole-Exome Sequencing in 10 Unrelated Patients with Syndromic Hidradenitis Suppurativa: A Preliminary Step for a Genotype-Phenotype Correlation","volume":"238","author":"Marzano","year":"2022","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2023.12.004_bib34","doi-asserted-by":"crossref","first-page":"e9324","DOI":"10.15252\/emmm.201809324","article-title":"OTULIN deficiency in ORAS causes cell type-specific LUBAC degradation, dysregulated TNF signalling and cell death","volume":"11","author":"Damgaard","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.det.2023.12.004_bib35","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.det.2023.12.004_bib36","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1182\/blood-2006-10-055087","article-title":"Mutations in the cofilin partner Aip1\/Wdr1 cause autoinflammatory disease and macrothrombocytopenia","volume":"110","author":"Kile","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.det.2023.12.004_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/vaccines11010162","article-title":"Autoinflammation in Syndromic Hidradenitis Suppurativa: The Role of AIM2","volume":"11","author":"Moltrasio","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.det.2023.12.004_bib38","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3390\/ijms23042278","article-title":"Variant Enrichment Analysis to Explore Pathways Functionality in Complex Autoinflammatory Skin Disorders through Whole Exome Sequencing Analysis","volume":"23","author":"Brand\u00e3o","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.det.2023.12.004_bib39","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/wrr.13014","article-title":"Spectrum of diseases associated with pyoderma gangrenosum and correlation with effectiveness of therapy: New insights on the diagnosis and therapy of comorbid hidradenitis suppurativa","volume":"30","author":"Fischer","year":"2022","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.det.2023.12.004_bib40","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.3390\/biomedicines9111735","article-title":"Acne Syndromes and Mosaicism","volume":"9","author":"Baroud","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.det.2023.12.004_bib41","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1159\/000509874","article-title":"A\u00a0Unified Concept of Acne in the PAPA Spectrum Disorders","volume":"237","author":"Maitrepierre","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2023.12.004_bib42","first-page":"38","article-title":"Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion","volume":"20","author":"Turcu","year":"2020","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.det.2023.12.004_bib43","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00384-014-2110-9","article-title":"Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis","volume":"30","author":"Murphy","year":"2015","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.det.2023.12.004_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000343602","article-title":"Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery","volume":"225","author":"Marzano","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2023.12.004_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14763","article-title":"A\u00a0case of PASH syndrome associated to testicular cancer","volume":"34","author":"Maione","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2023.12.004_bib46","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1111\/ajd.12438","article-title":"Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?","volume":"58","author":"Zivanovic","year":"2017","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib47","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1111\/ijd.12827","article-title":"PASH syndrome associated with osteopoikilosis","volume":"54","author":"Gracia-Caza\u00f1a","year":"2015","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib48","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ced.13909","article-title":"PASH syndrome with bony destruction","volume":"44","author":"McCarthy","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib49","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.jaad.2015.07.040","article-title":"Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients","volume":"73","author":"Join-Lambert","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdcr.2017.05.005","article-title":"Successful combined antibiotic therapy with oral clindamycin and oral rifampicin for pyoderma gangrenosum in patient with PASH syndrome","volume":"4","author":"Lamiaux","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib51","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/jdv.12765","article-title":"Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone","volume":"29","author":"Staub","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib52","article-title":"Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome: A Case Report and Literature Review","volume":"9","author":"Huang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.det.2023.12.004_bib53","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib54","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib55","doi-asserted-by":"crossref","DOI":"10.5070\/D32312037669","article-title":"Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab","volume":"23","author":"De Wet","year":"2017","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2023.12.004_bib56","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.3390\/biomedicines10102522","article-title":"Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study","volume":"10","author":"Burlando","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.det.2023.12.004_bib57","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00105-016-3840-0","article-title":"Schwere Akne bei Autoinflammationskrankheiten [Severe acne in autoinflammatory diseases]","volume":"67","author":"Faleri","year":"2016","journal-title":"Hautarzt"},{"key":"10.1016\/j.det.2023.12.004_bib58","first-page":"36","article-title":"Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa","volume":"10","author":"Sun","year":"2017","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib59","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1111\/ijd.13528","article-title":"Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier","volume":"56","author":"Jennings","year":"2017","journal-title":"Int J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.12.004_bib60","doi-asserted-by":"crossref","first-page":"e585","DOI":"10.1111\/ijd.16766","article-title":"A\u00a0case of PASH syndrome treated with guselkumab","volume":"62","author":"Marletta","year":"2023","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2023.12.004_bib61","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1111\/ajd.13285","article-title":"Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target","volume":"61","author":"Kok","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib62","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s13555-023-00913-3","article-title":"Efficacy and Safety of Risankizumab for the Treatment of Hidradenitis Suppurativa: A Phase 2, Randomized, Placebo-Controlled Trial","volume":"13","author":"Kimball","year":"2023","journal-title":"Dermatol Ther"},{"issue":"10","key":"10.1016\/j.det.2023.12.004_bib63","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/jdv.19252","article-title":"Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study","volume":"37","author":"Kimball","year":"2023","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib64","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/exd.14789","article-title":"Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: A prospective cohort study","volume":"32","author":"Flora","year":"2023","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib65","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/iwj.13403","article-title":"Wound care, adalimumab, and multidisciplinary approach in a patient affected by PASH syndrome","volume":"17","author":"Zagaria","year":"2020","journal-title":"Int Wound J"},{"key":"10.1016\/j.det.2023.12.004_bib66","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaad.2021.01.059","article-title":"Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations","volume":"86","author":"Garg","year":"2022","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib67","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.abd.2020.08.034","article-title":"PASH syndrome: a novel surgical approach","volume":"97","author":"Cawen","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib68","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamadermatol.2013.2907","article-title":"Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene","volume":"149","author":"Marzano","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib69","doi-asserted-by":"crossref","first-page":"587","DOI":"10.12659\/AJCR.898027","article-title":"Pyogenic Arthritis, Pyoderma Gangrenosum, Acne, Suppurative Hidradenitis (PA-PASH) Syndrome: An Atypical Presentation of a Rare Syndrome","volume":"17","author":"Ursani","year":"2016","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib70","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1111\/jdv.17171","article-title":"A\u00a0case of PAPASH syndrome in a young man carrying a novel heterozygote missense variant in PSTPIP1","volume":"35","author":"Kotzerke","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib71","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/24725625.2021.1881216","article-title":"A\u00a0case of myeloperoxidase-antineutrophil cytoplasmic antibody and anticardiolipin antibody-positive pyogenic arthritis, pyoderma gangrenosum, acne and hidradenitis suppurativa (PAPASH) syndrome with colitis","volume":"5","author":"Kawanishi","year":"2021","journal-title":"Mod Rheumatol Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib72","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/jdv.12631","article-title":"Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?","volume":"30","author":"Garzorz","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.medcli.2020.03.018","article-title":"PAPASH syndrome with MEFV gene mutation","volume":"156","author":"Monte Serrano","year":"2021","journal-title":"Med Clin"},{"key":"10.1016\/j.det.2023.12.004_bib74","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/bjd.18003","article-title":"PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens","volume":"181","author":"Gottlieb","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib75","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/bjd.16463","article-title":"Comorbidities of pyoderma gangrenosum: a retrospective multicentric analysis of 126 patients","volume":"179","author":"Gillard","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib76","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients","volume":"8","author":"Al Ghazal","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.det.2023.12.004_bib77","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib78","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2018.0878","article-title":"Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States","volume":"154","author":"Garg","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib79","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.11.040","article-title":"Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa","volume":"137","author":"Egeberg","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib80","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-4632.2007.03293.x","article-title":"Is there a role for infliximab in the current therapy of hidradenitis suppurativa? A report of three treated cases","volume":"46","author":"Moschella","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.immuni.2015.09.003","article-title":"Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability","volume":"43","author":"Lee","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.det.2023.12.004_bib82","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1080\/14712598.2021.1974395","article-title":"Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action","volume":"21","author":"Maronese","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.det.2023.12.004_bib83","article-title":"Ancient friends, revisited: Systematic review and case report of pyoderma gangrenosum-associated autoinflammatory syndromes","volume":"3","author":"Saternus","year":"2020","journal-title":"J\u00a0Transl Autoimmun"},{"key":"10.1016\/j.det.2023.12.004_bib84","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/j.jaad.2014.10.002","article-title":"PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition","volume":"72","author":"Saraceno","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib85","doi-asserted-by":"crossref","first-page":"381","DOI":"10.12688\/f1000research.52100.2","article-title":"Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab","volume":"10","author":"Nikolakis","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.det.2023.12.004_bib86","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/RHU.0b013e318278b84c","article-title":"Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor \u03b1 therapy","volume":"18","author":"Bruzzese","year":"2012","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib87","doi-asserted-by":"crossref","first-page":"e478","DOI":"10.1111\/jdv.16385","article-title":"PASS: a rare syndrome within the autoinflammatory diseases that still lacks a genetic marker","volume":"34","author":"Schwob","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib88","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000443648","article-title":"PASS Syndrome: An IL-1-Driven Autoinflammatory Disease","volume":"232","author":"Leuenberger","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.det.2023.12.004_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15507","article-title":"Secukinumab for PASS syndrome: A new choice for therapeutic challenge?","volume":"35","author":"Li","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2023.12.004_bib90","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jamadermatol.2015.3903","article-title":"Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial","volume":"152","author":"Tzanetakou","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib91","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jdcr.2016.11.006","article-title":"Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis","volume":"3","author":"Niv","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib92","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/jdv.18172","article-title":"Does SAPHO syndrome exist in dermatology?","volume":"36","author":"Chen","year":"2022","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib93","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s10067-005-0199-5","article-title":"A\u00a0hidradenitis suppurativa related SAPHO case associated with features resembling spondylarthropathy and proteinuria","volume":"26","author":"Ozyemisci-Taskiran","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib94","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3899\/jrheum.171007","article-title":"Is SAPHO Syndrome Linked to PASH Syndrome and Hidradenitis Suppurativa by Nicastrin Mutation? A Case Report","volume":"45","author":"Li","year":"2018","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl 6","key":"10.1016\/j.det.2023.12.004_bib95","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/jdv.15849","article-title":"Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate","volume":"33","author":"Genovese","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib96","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ijd.13740","article-title":"SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature","volume":"57","author":"Vekic","year":"2018","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib97","first-page":"185","article-title":"SAPHO syndrome associated with hidradenitis suppurativa successfully treated with infliximab and methotrexate","volume":"69","author":"De Souza","year":"2011","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.det.2023.12.004_bib98","article-title":"Hidradenitis suppurativa with SAPHO syndrome maintained effectively with adalimumab, methotrexate, and intralesional corticosteroid injections","volume":"6","author":"Crowley","year":"2018","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib99","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3899\/jrheum.130977","article-title":"Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study","volume":"41","author":"Richette","year":"2014","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib100","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3899\/jrheum.090456","article-title":"Genetic susceptibility factors in a cohort of 38 patients with SAPHO syndrome: a study of PSTPIP2, NOD2, and LPIN2 genes","volume":"37","author":"Hurtado-Nedelec","year":"2010","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib101","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3899\/jrheum.181393","article-title":"Copy Number Variation of Multiple Genes in SAPHO Syndrome","volume":"47","author":"Guo","year":"2020","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/clim.1998.4618","article-title":"Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent","volume":"90","author":"Klimiuk","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.det.2023.12.004_bib103","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbspin.2017.04.010","article-title":"SAPHO, autophagy, IL-1, FoxO1, and Propionibacterium (Cutibacterium) acnes","volume":"85","author":"Berthelot","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.det.2023.12.004_bib104","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/1756-185X.13741","article-title":"Association analysis of interleukin-23 receptor SNPs and SAPHO syndrome in Chinese people","volume":"22","author":"Guo","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.det.2023.12.004_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.643644","article-title":"Genome-Wide Association Identifies Risk Pathways for SAPHO Syndrome","volume":"9","author":"Cai","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.det.2023.12.004_bib106","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.semarthrit.2018.04.003","article-title":"Biologics in SAPHO syndrome: A systematic review","volume":"48","author":"Daoussis","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.det.2023.12.004_bib107","doi-asserted-by":"crossref","first-page":"656","DOI":"10.3899\/jrheum.211155","article-title":"Off-label Use of Secukinumab: A Potential Therapeutic Option for SAPHO Syndrome","volume":"49","author":"Wang","year":"2022","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.det.2023.12.004_bib108","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030065","article-title":"Exceptional response of skin symptoms to secukinumab treatment in a patient with SAPHO syndrome: Case report and literature review","volume":"101","author":"Ji","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.det.2023.12.004_bib109","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/ced.15087","article-title":"Successful treatment of synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with ixekizumab","volume":"47","author":"Xia","year":"2022","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2023.12.004_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14758","article-title":"SAPHO syndrome successful treated with tildrakizumab","volume":"34","author":"Licata","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2023.12.004_bib111","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jamadermatol.2020.3095","article-title":"Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome","volume":"157","author":"Li","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"11","key":"10.1016\/j.det.2023.12.004_bib112","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/1756-185X.14774","article-title":"Novel JAK-1 inhibitor upadacitinib as a possible treatment for refractory SAPHO syndrome: A case report","volume":"26","author":"Ma","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.det.2023.12.004_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13052-020-00933-1","article-title":"SAPHO syndrome: the supposed trigger by isotretinoin, the efficacy of adalimumab and the specter of depressive disorder: a case report","volume":"46","author":"Luzzati","year":"2020","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.det.2023.12.004_bib114","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13453","article-title":"Successful treatment of Sapho syndrome and hidradenitis suppurativa: A therapeutic challenge","volume":"33","author":"Fania","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2023.12.004_bib115","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3672","article-title":"Biologic Therapy for Hidradenitis Suppurativa Plus Conglobate Acne Associated with SAPHO Syndrome: A Case Report","volume":"100","author":"Briede","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.det.2023.12.004_bib116","first-page":"444","article-title":"Biologics for rare inflammatory diseases: TNF blockade in the SA PHO syndrome","volume":"70","author":"Burgemeister","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.det.2023.12.004_bib117","article-title":"Systemic Amyloidosis with Renal Failure: A Challenging Diagnosis of SAPHO Syndrome","volume":"6","author":"Correia","year":"2019","journal-title":"Eur J Case Rep Intern Med"},{"key":"10.1016\/j.det.2023.12.004_bib118","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s11606-019-05131-2","article-title":"SAPHO Syndrome from Hidradenitis Suppurativa","volume":"35","author":"Falahati","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.det.2023.12.004_bib119","first-page":"167","article-title":"Metotrexato no tratamento da s\u00edndrome SAPHO complicadas por quel\u00f3ides [Methotrexate to treat SAPHO syndrome with keloidal scars]","volume":"36","author":"Azevedo","year":"2011","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.det.2023.12.004_bib120","first-page":"A7857","article-title":"Een vrouw met pijn, stijfheid en huidafwijkingen [A woman with pain, stiffness and skin abnormalities]","volume":"158","author":"Louter","year":"2014","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.det.2023.12.004_bib121","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jdcr.2021.05.029","article-title":"Rapid and sustained remission of synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with IL-23p19 antagonist (risankizumab)","volume":"14","author":"Flora","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2023.12.004_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.911922","article-title":"SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.det.2023.12.004_bib123","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/jamasurg.2021.3655","article-title":"Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: The SHARPS Randomized Clinical Trial","volume":"156","author":"Bechara","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.det.2023.12.004_bib124","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project","volume":"82","author":"Garg","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2023.12.004_bib125","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1159\/000531496","article-title":"Clinical and molecular characterization of hidradenitis suppurativa: a practical framework for novel therapeutic targets","volume":"239","author":"Moltrasio","year":"2023","journal-title":"Dermatology"},{"issue":"4","key":"10.1016\/j.det.2023.12.004_bib126","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/bjd\/ljad224","article-title":"Has the time come to assess small molecule\/biologic drug combination for the management of moderate-to-severe hidradenitis suppurativa?","volume":"189","author":"Maronese","year":"2023","journal-title":"Br J Dermatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523001092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863523001092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:48:23Z","timestamp":1760006903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863523001092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":126,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0733863523001092"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2023.12.004","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis Suppurativa-Related Autoinflammatory Syndromes","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2023.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}